The authorized sale of a patented item exhausts the patent as to that item. However, how does the patent-exhaustion/first-sale doctrine apply in the context of self-replicating technology such as genetically modified or transgenic seed? Does the patent holder continue to have rights in the second generation item replicated from the patented object? Should it?
Firefox recommends the PDF Plugin for Mac OS X for viewing PDF documents in your browser.
We can also show you Legal Updates using the Google Viewer; however, you will need to be logged into Google Docs to view them.
Please choose one of the above to proceed!
LOADING PDF: If there are any problems, click here to download the file.